LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Review of outcomes of combination therapy using yttrium 90 radioembolization and sorafenib/nivolumab for HCC with hepatic vein or IVC invasion

    Shiqi Chung / Apoorva Gogna / Sivanathan Chandramohan / Richard Lo / Farah Gillan Irani / Nanda Venkatanarasimha

    Proceedings of Singapore Healthcare, Vol

    2023  Volume 32

    Abstract: Background A systematic review of the outcomes of combination therapy using Yttrium 90 radioembolization (Y90) and sorafenib/nivolumab for patients with hepatocellular carcinoma (HCC), with hepatic vein (HV) or inferior vena cava (IVC) invasion. The aim ... ...

    Abstract Background A systematic review of the outcomes of combination therapy using Yttrium 90 radioembolization (Y90) and sorafenib/nivolumab for patients with hepatocellular carcinoma (HCC), with hepatic vein (HV) or inferior vena cava (IVC) invasion. The aim of this study is to summarise the results of different studies that used the combination therapy for HCC patients with tumor thrombosis involving the HV or IVC. Method A literature search was performed using keywords in Medline and Google Scholar limited to publications from 2010 to 2021. There were 173 articles identified during the initial literature search. During abstract screening, 81 articles were excluded. Another 83 did not contain information on hepatic vein or IVC invasion. Therefore, 9 articles met the eligibility criteria and were included in the synthesis. Results In total, 37 patients with hepatic vein or IVC invasion were identified. There were 31 patients who were given sorafenib, 7 were given nivolumab and 1 was given both sorafenib and nivolumab. Among the 37 patients, 21 had hepatic vein invasion, 22 had IVC invasion and 6 had both HV and IVC invasion. The median OS was 20.55 months and median PFS was 8.18 months. For the results, 23 patients were evaluated via modified RECIST (mRECIST) criteria and 14 were evaluated via RECIST 1.1. Conclusion The combination of local and systemic therapies demonstrated potential results for increased response rates, OS and PFS benefits. Further studies are required to determine the long-term outcomes of the combination therapy for this group of patients.
    Keywords Medicine ; R
    Subject code 610
    Language English
    Publishing date 2023-01-01T00:00:00Z
    Publisher SAGE Publishing
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Radiochemical Feasibility of Mixing of

    Yang, Chang-Tong / Ngam, Pei Ing / Phua, Vanessa Jing Xin / Yu, Sidney Wing Kwong / Apoorva, Gogna / Ng, David Chee Eng / Huang, Hian Liang

    Molecules (Basel, Switzerland)

    2022  Volume 27, Issue 21

    Abstract: Yttrium-90 ( ...

    Abstract Yttrium-90 (
    MeSH term(s) Humans ; Microspheres ; Technetium Tc 99m Aggregated Albumin ; Iohexol ; Feasibility Studies ; Tomography, Emission-Computed, Single-Photon/methods ; Embolization, Therapeutic/methods ; Radiopharmaceuticals ; Liver Neoplasms/diagnostic imaging
    Chemical Substances Technetium Tc 99m Aggregated Albumin ; Iohexol (4419T9MX03) ; Radiopharmaceuticals
    Language English
    Publishing date 2022-11-07
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 1413402-0
    ISSN 1420-3049 ; 1431-5165 ; 1420-3049
    ISSN (online) 1420-3049
    ISSN 1431-5165 ; 1420-3049
    DOI 10.3390/molecules27217646
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top